Here’s whether Organon & Co. (OGN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+10.46% over 10 days); strong 1-year return of +40.6%; 3-month momentum positive (+62.1%); rising volume confirms the move (1.94x 30d avg). Concerns: RSI 80 — overbought, elevated pullback risk. Currently 0.8% off its 52-week high. Score: +6/7.
OGN is in a confirmed uptrend, trading above both its 50-day ($7.82) and 200-day ($8.45) moving averages. With an RSI of 80.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +40.6% compares to +24.4% for SPY (beat the market by 16.3%).
$10,000 invested 1 year ago→ $14,063 today
vs. S&P 500 (SPY) — same period beat market by 16.3%